glp-1 problems Patients with eating disorders are seeking — and getting — GLP-1s More people are turning to

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 133,45 per year only 11,12 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Ozempic and other GLP-1 medications are making headlines for their ability to regulate blood glucose and support weight management

Our Goal Our goal is to support you in achieving your optimal well-being by focusing on losing body fat (as opposed to just weight-loss), preserving existing muscle mass, fostering new healthy habits, and offering a structured exit strategy for when/if you choose to come off the medication

Patients who are already on basal insulin like Lantus and want a more concentrated option with potentially fewer injection-site reactions and slightly lower hypoglycemia risk